US Judge Finds Biogen, Inc. Breached Pact with Biogen (JOBS)

Bookmark and Share

Reuters -- Irish drugmaker Elan Corp PLC breached a collaboration agreement with Biogen Idec Inc for the multiple sclerosis drug Tysabri in making a deal with Johnson & Johnson, a U.S. judge ruled on Thursday.
MORE ON THIS TOPIC